The practice of medicine is one where innovation is literally a matter of life or death, there's always an urgent need for a new test to diagnose a mysterious new disease and a new miracle treatment to save someone afflicted by it. Innovation in healthcare is essential, and those pushing medicine's boundaries have the supreme motivation to do so; they want to alleviate suffering and save lives. As we turn the corner on 2020, we find ourselves in the midst of the worst pandemic in a century and humanity's brightest minds are focused on rapidly innovating healthcare solutions for pandemic-scale problems to save lives. The failure to scale healthcare systems over the last few decades has resulted in intense pressure to scale pandemic response in months; it is unequivocally clear that as a result our health systems will be transformed in the post pandemic world. Let's explore the major anticipated transformation. In the decade since 2010, smart phones "apps" went from buzzwords to integral parts of healthcare delivery.
Waiting 72 hours to receive COVID-19 test results can feel like forever. To speed up that process for urgent, priority patients, eHealth NSW has partnered with Microsoft to use cloud technology and artificial intelligence to reduce the waiting period to three hours. NSW Health Pathology, which has been charged with overseeing COVID-19 testing clinics, has deployed rapid testing for COVID-19 to 35 portable point-of-care devices, so patients can be tested anywhere before their data is uploaded to Azure cloud via 4G connectivity and is reviewed by a clinician -- no matter their location -- in near real-time. "I think with remote monitoring and remote testing you can start to change service models so you can have self-service in communities. That's how you're improving the quality of care, not just the availability of care," NSW Health Pathology CIO James Patterson said.
FUJIFILM SonoSite, Inc. has announced the launch of a strategic relationship with Partners HealthCare to apply artificial intelligence to improve the utility and functionality of portable ultrasound. The two organizations will collaborate to enhance ultrasound technology with AI to enable clinicians to perform scans at the point-of-care, further expanding the accessibility of this technology for clinicians and their patients. The collaboration will be executed through the MGH & BWH Center for Clinical Data Science and leverage the extensive data assets, computational infrastructure and clinical expertise of the Partners HealthCare system. Allowing for even greater integration of ultrasound into our healthcare delivery system requires smarter machines. In emergency settings, the efficiency and cost-effectiveness of portable ultrasound makes is a critical companion to other imaging modalities." The first project under the collaboration will target some of the more complex emergency medicine procedures using AI enabled portable ultrasound. Andrew Liteplo, MD, MGH Department of Emergency Medicine, explains, "If we build scanners that can be used by non-expert users both inside and outside the hospital, we can likely reduce the time delay between trauma and diagnosis, which will translate to more rapid interventions and improved outcomes." Diku Mandavia, MD, FACEP, FRCPC, Senior Vice President and Chief Medical Officer of FUJIFILM SonoSite emphasizes, "This collaboration is really focused on embedding AI in portable ultrasound with the goal of providing assistance in 2D image interpretation along with the automation of measurements and calculations - the type of automation that will allow us to increase the accessibility of this critical technology while still delivering high diagnostic value." FUJIFILM SonoSite introduced ultrasound systems designed for use at the point of care to the healthcare system over 20 years ago. We have always listened carefully to our customers to ensure their needs are being met and I am proud that we will be able to offer them AI enhanced technology to expand their utilization of ultrasound, increasing the quality of care they can provide while saving our healthcare system money."
Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com. The Food and Drug Administration (FDA) granted Assure Tech emergency use authorization for a point-of-care test capable of detecting past COVID-19 infections through blood samples. In July, the Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for emergency use by some labs to identify individuals with antibodies to SARS-CoV-2, indicating a recent or prior infection to COVID-19. As of Wednesday, the test is now authorized for point-of-care use using a blood sample from the fingertip.
On a seemingly normal summer day nine years ago, planet Earth was struck by a gadget-sized blow that would reinvent nearly every facet of our lives. That day heralded the entry of the iPhone, which eventually ushered in a world of fast, seamless, virtual communication as well as instant access to the world's information. Today, roughly 2 billion of us own smartphones, and collectively we spend many billions of minutes on the likes of Facebook, Twitter, Snapchat and Google Maps. Smartphones exert an almost gravitational pull on our attention spans. Research by Dscout suggests that, on average, we touch our screens over 2,500 times a day.